Nephros (NASDAQ:NEPH) Shares Down 0.5%

Nephros, Inc. (NASDAQ:NEPH)’s stock price was down 0.5% during mid-day trading on Monday . The stock traded as low as $1.97 and last traded at $1.99. Approximately 7,676 shares were traded during trading, a decline of 62% from the average daily volume of 20,068 shares. The stock had previously closed at $2.00.

Nephros Price Performance

The firm’s fifty day moving average price is $2.72 and its 200-day moving average price is $2.62. The company has a market capitalization of $20.98 million, a price-to-earnings ratio of -13.33 and a beta of 1.30.

Nephros (NASDAQ:NEPH) last issued its quarterly earnings data on Thursday, March 7th. The company reported ($0.06) earnings per share for the quarter. Nephros had a negative return on equity of 18.25% and a negative net margin of 11.06%. The business had revenue of $3.25 million during the quarter.

Institutional Trading of Nephros

Several institutional investors have recently modified their holdings of the business. Geode Capital Management LLC boosted its position in Nephros by 595.0% during the second quarter. Geode Capital Management LLC now owns 77,344 shares of the company’s stock valued at $120,000 after acquiring an additional 66,216 shares during the last quarter. Susquehanna International Group LLP bought a new stake in Nephros during the first quarter valued at $39,000. Vanguard Group Inc. boosted its position in Nephros by 20.5% during the third quarter. Vanguard Group Inc. now owns 147,783 shares of the company’s stock valued at $134,000 after acquiring an additional 25,105 shares during the last quarter. Renaissance Technologies LLC bought a new stake in Nephros during the first quarter valued at $89,000. Finally, Wexford Capital LP boosted its position in Nephros by 0.4% during the first quarter. Wexford Capital LP now owns 3,663,969 shares of the company’s stock valued at $533,734,000 after acquiring an additional 13,440 shares during the last quarter. Institutional investors own 41.10% of the company’s stock.

About Nephros

Nephros, Inc engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.